ANDA 40045, held by Cosette Pharmaceuticals. Quinidine Sulfate.
As of Nov 21, 2026, ANDA 40045 (Quinidine Sulfate), held by Cosette Pharmaceuticals, was first approved by FDA on Jun 30, 1994, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 30, 1994 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Quinidine Sulfate300MG · tablet, extended release;oral | Quinidine Sulfate | Discontinued |
| Oct 3, 2003 | Supplement 16Labeling | Approved | None posted |
| Jan 23, 2002 | Supplement 8Manufacturing | Approved | None posted |
| Oct 31, 2001 | Supplement 9Manufacturing | Approved | None posted |
| Oct 31, 2001 | Supplement 10Manufacturing | Approved | None posted |
| Oct 31, 2001 | Supplement 11Manufacturing | Approved | None posted |
| Jul 15, 1999 | Supplement 5Manufacturing | Approved | None posted |
| May 26, 1999 | Supplement 7Labeling | Approved | None posted |
| Mar 23, 1999 | Supplement 6Manufacturing | Approved | None posted |
| Jul 26, 1996 | Supplement 3Labeling | Approved | None posted |
| May 31, 1996 | Supplement 2Manufacturing | Approved | None posted |
| Mar 19, 1996 | Supplement 1Manufacturing | Approved | None posted |
| Jun 30, 1994 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters